United States · FDA National Drug Code directory
pregabalin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43598-291_4a1e5038-d049-606f-c087-48bc353a8a69
- Product NDC
- 43598-291
- Form
- CAPSULE
- Composition / generic term
- pregabalin
- Labeler
- Dr.Reddys Laboratories Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190719
- Source listing expiry
- 20261231
Source-listed ingredients
- PREGABALIN — 25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 CAPSULE in 1 BOTTLE (43598-291-05) · 43598-291-05
- 5 BLISTER PACK in 1 CARTON (43598-291-66) / 10 CAPSULE in 1 BLISTER PACK (43598-291-79) · 43598-291-66
- 10 BLISTER PACK in 1 CARTON (43598-291-78) / 10 CAPSULE in 1 BLISTER PACK (43598-291-79) · 43598-291-78
- 90 CAPSULE in 1 BOTTLE (43598-291-90) · 43598-291-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →